• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病的全球流行病学:一项更新的系统评价和荟萃分析。

Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis.

机构信息

Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University.

NHC Key Laboratory of Food Safety Risk Assessment, China National Center for Food Safety Risk Assessment.

出版信息

J Pediatr Hematol Oncol. 2023 May 1;45(4):181-188. doi: 10.1097/MPH.0000000000002506. Epub 2022 Jul 22.

DOI:10.1097/MPH.0000000000002506
PMID:35867706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10115488/
Abstract

BACKGROUND

Gaucher disease [GD], an autosomal recessive lysosomal storage disorder, is characterized by progressive lysosomal storage of glucocerebroside in macrophages predominantly in bone, bone marrow, liver, and spleen. Meta-analysis of global GD epidemiology was not available before this study.

METHODS

To provide a systematic review and meta-analysis of birth prevalence and prevalence of GD in multiple countries. MEDLINE and EMBASE databases were searched for original research articles on the epidemiology of GD from inception until July 21, 2021. Meta-analysis, adopting a random-effects logistic model, was performed to estimate the birth prevalence and prevalence of GD.

RESULTS

Eighteen studies that were screened of 1874 records were included for data extraction. The studies that fulfilled the criteria for inclusion involved 15 areas/countries. The global birth prevalence of GD was 1.5 cases [95% confidence interval: 1.0 to 2.0] per 100,000 live births. The global prevalence of GD was 0.9 cases [95% confidence interval: 0.7 to 1.1] per 100,000 inhabitants.

CONCLUSIONS

This is the first comprehensive systematic review that presented quantitative data of GD global epidemiology. Quantitative data on global epidemiology of GD could be the fundamental to evaluate the global efforts on building a better world for GD patients.

摘要

背景

戈谢病[GD]是一种常染色体隐性溶酶体贮积病,其特征是葡萄糖脑苷脂在巨噬细胞中进行进行性溶酶体贮积,主要发生在骨骼、骨髓、肝脏和脾脏。在此项研究之前,全球 GD 流行病学的荟萃分析尚不可用。

方法

对多个国家的戈谢病的发病情况进行系统回顾和荟萃分析。检索 MEDLINE 和 EMBASE 数据库,以获取关于 GD 流行病学的原始研究文章,检索时间从建库至 2021 年 7 月 21 日。采用随机效应逻辑模型进行荟萃分析,以估计 GD 的发病情况。

结果

对 1874 条记录进行筛选后,有 18 项研究符合纳入标准并进行了数据提取。符合纳入标准的研究涉及 15 个地区/国家。全球 GD 的出生患病率为 1.5 例[95%置信区间:1.0 至 2.0]每 100,000 例活产。全球 GD 的患病率为 0.9 例[95%置信区间:0.7 至 1.1]每 100,000 名居民。

结论

这是第一项全面的戈谢病全球流行病学系统评价,提供了定量数据。定量数据可用于评估全球为戈谢病患者建立更美好世界的努力。

相似文献

1
Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis.戈谢病的全球流行病学:一项更新的系统评价和荟萃分析。
J Pediatr Hematol Oncol. 2023 May 1;45(4):181-188. doi: 10.1097/MPH.0000000000002506. Epub 2022 Jul 22.
2
Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis.全球黏多糖贮积症 III 型(Sanfilippo 综合征)的流行病学:一项更新的系统评价和荟萃分析。
J Pediatr Endocrinol Metab. 2021 Jul 19;34(10):1225-1235. doi: 10.1515/jpem-2020-0742. Print 2021 Oct 26.
3
Global birth prevalence of Pompe disease: A systematic review and meta-analysis.庞贝病的全球出生患病率:一项系统评价和荟萃分析。
Neuroscience. 2024 Dec 17;563:167-174. doi: 10.1016/j.neuroscience.2024.09.043. Epub 2024 Oct 16.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Gaucher disease epidemiology and natural history: a comprehensive review of the literature.戈谢病的流行病学与自然史:文献综述
Hematology. 2017 Mar;22(2):65-73. doi: 10.1080/10245332.2016.1240391. Epub 2016 Oct 20.
6
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.全球杜氏肌营养不良症的流行病学:一项更新的系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Jun 5;15(1):141. doi: 10.1186/s13023-020-01430-8.
7
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.血浆壳三糖苷酶活性与CCL18水平用于评估I型戈谢病严重程度:个体参与者数据的系统评价与荟萃分析方案
Syst Rev. 2017 Apr 20;6(1):87. doi: 10.1186/s13643-017-0483-x.
8
Gaucher disease and its treatment options.戈谢病及其治疗选择。
Ann Pharmacother. 2013 Sep;47(9):1182-93. doi: 10.1177/1060028013500469.
9
Velaglucerase alfa for the management of type 1 Gaucher disease.依洛硫酸酯酶α治疗戈谢病 1 型。
Clin Ther. 2012 Feb;34(2):259-71. doi: 10.1016/j.clinthera.2011.12.017. Epub 2012 Jan 20.
10
Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.将肝硬度与戈谢病 1 型(GD1)患者疾病严重程度评分系统(DS3)值相关联。
Mol Genet Metab. 2018 Mar;123(3):357-363. doi: 10.1016/j.ymgme.2017.10.013. Epub 2018 Jan 5.

引用本文的文献

1
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three Decades.法国戈谢病的流行病学:三十年期间发病率、死亡率、治疗及并发症的变化趋势
J Inherit Metab Dis. 2025 May;48(3):e70037. doi: 10.1002/jimd.70037.
2
Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey.利用戈谢病结果调查的数据评估溶血神经酰胺单己糖(Lyso-Gb1)作为戈谢病治疗效果生物标志物的情况。
Orphanet J Rare Dis. 2025 Jan 29;20(1):43. doi: 10.1186/s13023-024-03444-y.
3
An Overview of Gaucher Disease.
戈谢病概述
Diagnostics (Basel). 2024 Dec 17;14(24):2840. doi: 10.3390/diagnostics14242840.
4
Current opinion on pluripotent stem cell technology in Gaucher's disease: challenges and future prospects.高雪氏病中多能干细胞技术的当前观点:挑战与未来前景
Cytotechnology. 2025 Feb;77(1):26. doi: 10.1007/s10616-024-00687-2. Epub 2024 Dec 27.
5
Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction.神经病变型戈谢病患者成纤维细胞中 GM1-神经节苷脂的二次蓄积鉴定及三羟哌啶基亚氨基糖化合物对其蓄积减少的作用。
Molecules. 2024 Jan 17;29(2):453. doi: 10.3390/molecules29020453.
6
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification.药理学伴侣在溶酶体贮积症中的治疗作用:证据回顾与再分类的明智方法。
Biomolecules. 2023 Aug 7;13(8):1227. doi: 10.3390/biom13081227.
7
Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study.日本神经病变型和非神经病变型戈谢病患者照料者的负担:一项基于调查的研究。
Mol Genet Metab Rep. 2023 Aug 1;36:100994. doi: 10.1016/j.ymgmr.2023.100994. eCollection 2023 Sep.
8
Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review.戈谢病的全球发病率和患病率:一项针对性文献综述。
J Clin Med. 2022 Dec 22;12(1):85. doi: 10.3390/jcm12010085.